Inventor · disambiguated record
Justin Blake Bartlett
Also filed as: BARTLETT JUSTIN B · BARTLETT JUSTIN BLAKE
3 granted patents·6 pending applications·53 citations·filing 2006–2021
69Inventor score
Top patents by PatentIndex Score
9 records- 0189US8715677B2Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapyBARTLETT JUSTIN B·Filed 2006·Granted May 6, 2014·48 cites·15 claims
- 0270US10925867B2Immunotherapeutic dosing regimens comprising pomalidomide and an anti-CS1 antibody for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 23, 2021·1 cites·3 claims
- 0367US8841325B2Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitamin D resistant tumor cellsBROSSEAU CAROLE·Filed 2010·Granted Sep 23, 2014·4 cites·15 claims
- 0457US2010098657A1Method of Treating Cancer with Immunomodulatory Compounds and IgGSCHAFER PETER H·Filed 2008·Application pending·0 cites
- 0555US2021154183A1Immunotherapeutic dosing regimens comprising pomalidomide and an anti-cs1 antibody for treating cancerBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 0652US2009148853A1Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphomaSCHAFER PETER H·Filed 2008·Application pending·0 cites
- 0751US2016153998A1Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphomaCELGENE CORP·Filed 2015·Application pending·0 cites
- 0845US2015283124A1Immunomodulatory Compounds for the Restoration of Vitamin D Sensitivity in Vitamin D Resistant Tumor CellsCELGENE CORP·Filed 2014·Application pending·0 cites
- 0942US2012190110A1Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapyBARTLETT JUSTIN B·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Justin Blake Bartlett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →